SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
Clinical trial NCT04090710 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04090710
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2026-06-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.